methylphenidate modified release capsules - 8 hrs acting / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylphenidate modified release capsules - 8 hrs acting / Generic mfg.
NCT00302354: A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults

Completed
4
50
US
OROS methylphenidate HCl, SODAS methylphenidate HCl
Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Healthy Volunteers
09/05
09/05
NCT00257725: Long-Duration Stimulant Treatment Study of ADHD in Young Children

Completed
4
11
US
B-MPH, Ritalin LA
New York State Psychiatric Institute
Attention Deficit Disorder With Hyperactivity
03/08
03/08
NCT00754208: Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children

Completed
4
7
US
methylphenidate, Ritalin, Methylin, Ritalin LA
University of Nebraska
Attention Deficit Hyperactivity Disorder
01/10
01/10
NCT01393574: Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties

Unknown status
4
46
RoW
Melatonin, Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Concerta
Assaf-Harofeh Medical Center
Attention Deficit Hyperactivity Disorder, Sleep Onset Insomnia
06/12
 
NCT01673594: Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

Completed
4
37
US
SODAS MPH, Ritalin LA, Naltrexone, Naltrexone HCl
Massachusetts General Hospital, United States Department of Defense
ADHD, Stimulant-Induced Euphoria
06/15
06/15
NCT02063945: Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

Terminated
4
5
RoW
Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Concerta, Risperidone, Risperdal
Sheba Medical Center
Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder
02/18
02/18
NCT00863499 / 2009-013272-47: International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder

Unknown status
4
1344
Europe, US, RoW
Short Acting Methylphenidate, • Ritalin, • Ritalina, • Attenta, • Methylin, • Penid, • Rubifen, *Consider treatment directions above or as physician directed as per usual care., Long Acting Methylphenidate, • Concerta, • Metadate CD, • Methylin ER, • Ritalin LA, • Ritalin Sustained-Release
BRC Operations Pty. Ltd.
Attention Deficit/Hyperactivity Disorder
12/19
12/19
FASST, NCT04968522: - Fetal Alcohol Spectrum Stimulant Trial

Recruiting
4
20
RoW
Methylphenidate Hydrochloride, Ritalin 10 tablets, Placebo, Methylphenidate hydrochloride, Ritalin LA Long acting capsules, Methylphenidate Hydrochloride 18 MG, Concerta, Dexamphetamine sulfate, Aspen Dexamfetamine Tablets
Monash Medical Centre, Monash University
Fetal Alcohol Spectrum Disorders
04/23
07/23

Download Options